GPR35 mediates monocyte recruitment to the sites of Listeria monocytogenes infection
Cellular and Molecular Life Sciences · 02.12.2025 · 82 (1)
DOI: 10.1007/s00018-025-05912-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Life Sciences, online erschienen am 02.12.2025. Verfasst von Yo Okamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology and Immunology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, 422-8526, Japan. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Monocytes, Listeriosis, Listeria monocytogenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Terumo Foundation for Life Sciences and Arts.
Abstract (Originalsprache)
Recruitment of Ly6Chi monocytes to infection sites critically contributes to the clearance of microbial pathogens. However, the mechanism regulating their migration from the peripheral blood to the infected sites remains unresolved. In this study, we demonstrate that G protein-coupled receptor GPR35 is required for the entry of circulating Ly6Chi monocytes into the sites of Listeria monocytogenes infection. Gpr35-/- mice showed a decrease in Ly6Chi monocyte recruitment to the cecum and colon after oral administration of L. monocytogenes. They also exhibited a reduction in Ly6Chi monocytes in the liver and spleen upon intravenous infection. Mechanistically, GPR35 signaling enhanced Mac-1- and LFA-1-dependent Ly6Chi monocyte adhesion to ICAM-1, and GPR35-dependent integrin activation was important for their in vivo recruitment to infected sites. A potential GPR35-reactive metabolite, lysophosphatidic acid, accumulated around the bacterial foci near to the blood vessels. In addition, the GPR35 signal induced TNF-α production by Ly6Chi Sca-1+ monocytes and restricted the bacterial burden of L. monocytogenes. Collectively, GPR35-mediated signaling provides the molecular cue for elimination of L. monocytogenes by recruiting circulating Ly6Chi monocytes to the infected sites where they produce TNF-α.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microbiology and Immunology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, 422-8526, Japan.
- Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.
- Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Osaka, 565-0871, Japan.
- Laboratory of Reproductive Systems Biology, Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.
- Human Biology Microbiome Quantum Research Center (WPI-Bio2Q), Keio University School of Medicine, Tokyo, 160-8582, Japan.
- Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
Förderung
- Terumo Foundation for Life Sciences and Arts
Zitieren
APA
Okamura, Y., Nakanishi, K., Inada, R., Maeda, R., Maeshima, K., Mizutani, M., Ohashi, W., Ikawa, M., Sugiura, Y., Takeda, K., & Umemoto, E. (2025). GPR35 mediates monocyte recruitment to the sites of Listeria monocytogenes infection. Cellular and Molecular Life Sciences, 82(1). https://doi.org/10.1007/s00018-025-05912-5
Vancouver
Okamura Y, Nakanishi K, Inada R, Maeda R, Maeshima K, Mizutani M, et al. GPR35 mediates monocyte recruitment to the sites of Listeria monocytogenes infection. Cellular and Molecular Life Sciences. 2025;82(1). doi:10.1007/s00018-025-05912-5
BibTeX
@article{Okamura2025,
author = {Okamura, Yo and Nakanishi, Katsuhiro and Inada, Ryotaro and Maeda, Rae and Maeshima, Kazuki and Mizutani, Misato and Ohashi, Wakana and Ikawa, Masahito and Sugiura, Yuki and Takeda, Kiyoshi and Umemoto, Eiji},
title = {GPR35 mediates monocyte recruitment to the sites of Listeria monocytogenes infection},
journal = {Cellular and Molecular Life Sciences},
year = {2025},
volume = {82},
number = {1},
doi = {10.1007/s00018-025-05912-5}
}
EUVIMED